ConductScience.org, home

Trial · NCT07905742

Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, and Function

NCT07905742, Not applicable, Active not recruiting, University of Management and Technology Lahore

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, and Function. Trials, record NCT07905742. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905742

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, and Function
NCT number
NCT07905742
Status
Active not recruiting
Phases
Not applicable
Enrollment
34 participants, actual
Lead sponsor
University of Management and Technology Lahore
Conditions
Shoulder Pain and Stiffness
Interventions
Scapular Stabilization, Conventional treatment
First posted
2026-10-29
Last updated
2026-11-02

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumeric Pain Rating ScaleBaseline and after 6 weeks
11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform)
PrimaryHand Held DynamometerBaseline and after 6 weeks
Rotator cuff strength will be measured with a handheld dynamometer (microFET2) using the make-test method, in which the participant pushes maximally against the device while the examiner holds it stationary. External and internal rotation will be tested with the participant seated, the arm at the side with a small towel roll under the elbow and the elbow flexed to 90°, with the device placed just proximal to the wrist on the posterior and anterior surfaces of the forearm, respectively. Scaption strength will be tested with the arm elevated to approximately 90° in the scapular plane with the thumb pointing upward, and the device placed on the upper surface of the forearm just above the wrist.
PrimaryShoulder Pain and Disability IndexBaseline and after 6 weeks
Shoulder pain and function will be assessed with the Shoulder Pain and Disability Index (SPADI), a self-administered 13-item questionnaire. It has a five-item pain subscale and an eight-item disability subscale, each item rated from 0 (no pain or difficulty) to 10 (worst pain or so difficult that help is needed). Each subscale is converted to a percentage, and the total score is the mean of the two (0 to 100), with higher scores indicating greater pain and disability.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07905742

GET https://conductscience.org/api/trials/v1/NCT07905742/registered